Business Standard

Spike protein vaccines may help fight Covid variants: IIT-M study

Researchers sought to gauge the response in cases where post-vaccination infections were caused by a variant other than the original Wuhan strain

Coronavirus vaccine
Premium

While further experimental verification is called for, the researchers believe that the present spike protein vaccines are likely to be efficacious against circulating variants of Coronavirus

BS Reporter Chennai
Spike protein vaccines may be effective against multiple variants of the coronavirus (SARS COV-2), according to a study by researchers at Indian Institute of Technology Madras (IIT Madras). The spike protein is one of the four major proteins found in coronaviruses; it helps the Sars-CoV-2 virus to latch on to a host cell and, in turn, infect the body eventually.

The results of the study suggest that the threat from the selected variants — Delta plus, Gamma, Zeta, Mink and Omicron — may be dealt with by vaccine-induced T cell responses in spite of having compromised neutralising antibodies. T cells are

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Sep 27 2022 | 6:17 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com